RxDoctor Payments DataLook up a doctor →

Armodios Hatzidakis, MD

Adult Reconstructive Orthopaedic Surgery · Denver, CONPI 1124031125

Payments from drug & device makers

$1,871,489in general payments, 2019–2025

Across 960 payments — averaging $1949.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.4M
  • Smith+Nephew$317K
  • Arthrex$54K
  • Lima USA, Inc.$34K
  • Exactech, Inc.$11K
  • Shoulder Innovations, Inc.$8K
  • plus $14K from 23 others
$14,191in research payments, 2019–2025

Across 12 payments — averaging $1182.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exactech, Inc.$12K
  • Stryker$2K

What the payments were for

  • Royalty or licence$693,92349%
  • Consulting fees$587,27442%
  • Speaking & faculty fees$49,8234%
  • Travel & lodging$63,8215%
  • Food & beverage$17,5051%
  • Education$1,2000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,871,489 in reported general payments places this provider in the 95th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.

See all adult reconstructive orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$339,637
Medicare patients
517
Services billed
2,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib56$1,365
Amoxicillin12$12

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →